578 filings
Page 8 of 29
S-3ASR
t82 0z0w1z
12 May 14
Automatic shelf registration
12:00am
10-KT/A
guamfh9
12 May 14
Annual report (with FYE transition) (amended)
12:00am
8-A12G/A
dm9ud
9 May 14
Registration of securities (amended)
12:00am
8-K
65ewoyd098zsg ekzm3
8 May 14
Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update
12:00am
8-K
hjhg 58qfxx8xeokqsz
13 Mar 14
Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Corporate Update
12:00am
8-K
7p5nuepkggruuhjd1u1
26 Feb 14
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
k0zqd0vmj74wj zt
24 Feb 14
18 Month Clinical Results Showed Significantly Slower Progression of Total Motor Score in RP103 Treated Patients Without Tetrabenazine
12:00am
8-K
mmj1ft
22 Jan 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
ig5hlhzq2krsx5zg
14 Jan 14
Raptor Announces Full Enrollment of Phase 2b Trial of RP103 for Non-Alcoholic Fatty Liver Disease in Children
12:00am
8-K
jyxpx39k 4r
12 Dec 13
Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders
12:00am
CT ORDER
vsvjeplgj 2om167sct
19 Nov 13
Confidential treatment order
12:00am
8-K
feqarvzxfc p4euzbxg
7 Nov 13
Third Quarter 2013 Financial Results
12:00am
8-K
5zrmbpc5727 nhfh
12 Sep 13
Other Events
12:00am